BUY CHAPTERS

Genitourinary Drugs Market Insights, Forecast to 2028

Code: QYRE-Auto-38T2103

Report

February 2022

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Genentech Inc

China

India

Genitourinary Drugs Market Outlook - 2028

Due to the COVID-19 pandemic, the global Genitourinary Drugs market size is estimated to be worth US$ 29570 million in 2022 and is forecast to a readjusted size of US$ 35930 million by 2028 with a CAGR of 3.3% during the review period.

Genitourinary market

Fully considering the economic change by this health crisis, Urologicals accounting for % of the Genitourinary Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Prostate Cancer segment is altered to an % CAGR throughout this forecast period.

Genitourinary Drugs Market Insights

China Genitourinary Drugs market size is valued at US$ million in 2021, while the US and Europe Genitourinary Drugs are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Genitourinary Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

The global key manufacturers of Genitourinary Drugs include Novartis AG and Genentech etc. In 2021, the global top five players have a share approximately % in terms of revenue.

Genitourinary Drugs Market Scope and Segment

Genitourinary Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Genitourinary Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Urologicals
Hormonal Therapy
Gynecological
Anti-infectives

Segment by Application

Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence & Overactive Bladder
Sexually Transmitted Diseases

By Company

Novartis AG
Genentech

By Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

1 Study Coverage

1.1 Genitourinary Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Genitourinary Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Urologicals

1.2.3 Hormonal Therapy

1.2.4 Gynecological

1.2.5 Anti-infectives

1.3 Market by Application

1.3.1 Global Genitourinary Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Prostate Cancer

1.3.3 Ovarian Cancer

1.3.4 Bladder Cancer

1.3.5 Cervical Cancer

1.3.6 Renal Cancer

1.3.7 Erectile Dysfunction

1.3.8 Urinary Tract Infections

1.3.9 Urinary Incontinence & Overactive Bladder

1.3.10 Sexually Transmitted Diseases

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Genitourinary Drugs Sales Estimates and Forecasts 2017-2028

2.2 Global Genitourinary Drugs Revenue Estimates and Forecasts 2017-2028

2.3 Global Genitourinary Drugs Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Genitourinary Drugs Sales by Region

2.4.1 Global Genitourinary Drugs Sales by Region (2017-2022)

2.4.2 Global Sales Genitourinary Drugs by Region (2023-2028)

2.5 Global Genitourinary Drugs Revenue by Region

2.5.1 Global Genitourinary Drugs Revenue by Region (2017-2022)

2.5.2 Global Genitourinary Drugs Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Genitourinary Drugs Sales by Manufacturers

3.1.1 Global Top Genitourinary Drugs Manufacturers by Sales (2017-2022)

3.1.2 Global Genitourinary Drugs Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Genitourinary Drugs in 2021

3.2 Global Genitourinary Drugs Revenue by Manufacturers

3.2.1 Global Genitourinary Drugs Revenue by Manufacturers (2017-2022)

3.2.2 Global Genitourinary Drugs Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Genitourinary Drugs Revenue in 2021

3.3 Global Genitourinary Drugs Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Genitourinary Drugs Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Genitourinary Drugs Sales by Type

4.1.1 Global Genitourinary Drugs Historical Sales by Type (2017-2022)

4.1.2 Global Genitourinary Drugs Forecasted Sales by Type (2023-2028)

4.1.3 Global Genitourinary Drugs Sales Market Share by Type (2017-2028)

4.2 Global Genitourinary Drugs Revenue by Type

4.2.1 Global Genitourinary Drugs Historical Revenue by Type (2017-2022)

4.2.2 Global Genitourinary Drugs Forecasted Revenue by Type (2023-2028)

4.2.3 Global Genitourinary Drugs Revenue Market Share by Type (2017-2028)

4.3 Global Genitourinary Drugs Price by Type

4.3.1 Global Genitourinary Drugs Price by Type (2017-2022)

4.3.2 Global Genitourinary Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Genitourinary Drugs Sales by Application

5.1.1 Global Genitourinary Drugs Historical Sales by Application (2017-2022)

5.1.2 Global Genitourinary Drugs Forecasted Sales by Application (2023-2028)

5.1.3 Global Genitourinary Drugs Sales Market Share by Application (2017-2028)

5.2 Global Genitourinary Drugs Revenue by Application

5.2.1 Global Genitourinary Drugs Historical Revenue by Application (2017-2022)

5.2.2 Global Genitourinary Drugs Forecasted Revenue by Application (2023-2028)

5.2.3 Global Genitourinary Drugs Revenue Market Share by Application (2017-2028)

5.3 Global Genitourinary Drugs Price by Application

5.3.1 Global Genitourinary Drugs Price by Application (2017-2022)

5.3.2 Global Genitourinary Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Genitourinary Drugs Market Size by Type

6.1.1 North America Genitourinary Drugs Sales by Type (2017-2028)

6.1.2 North America Genitourinary Drugs Revenue by Type (2017-2028)

6.2 North America Genitourinary Drugs Market Size by Application

6.2.1 North America Genitourinary Drugs Sales by Application (2017-2028)

6.2.2 North America Genitourinary Drugs Revenue by Application (2017-2028)

6.3 North America Genitourinary Drugs Market Size by Country

6.3.1 North America Genitourinary Drugs Sales by Country (2017-2028)

6.3.2 North America Genitourinary Drugs Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Genitourinary Drugs Market Size by Type

7.1.1 Europe Genitourinary Drugs Sales by Type (2017-2028)

7.1.2 Europe Genitourinary Drugs Revenue by Type (2017-2028)

7.2 Europe Genitourinary Drugs Market Size by Application

7.2.1 Europe Genitourinary Drugs Sales by Application (2017-2028)

7.2.2 Europe Genitourinary Drugs Revenue by Application (2017-2028)

7.3 Europe Genitourinary Drugs Market Size by Country

7.3.1 Europe Genitourinary Drugs Sales by Country (2017-2028)

7.3.2 Europe Genitourinary Drugs Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Genitourinary Drugs Market Size by Type

8.1.1 Asia Pacific Genitourinary Drugs Sales by Type (2017-2028)

8.1.2 Asia Pacific Genitourinary Drugs Revenue by Type (2017-2028)

8.2 Asia Pacific Genitourinary Drugs Market Size by Application

8.2.1 Asia Pacific Genitourinary Drugs Sales by Application (2017-2028)

8.2.2 Asia Pacific Genitourinary Drugs Revenue by Application (2017-2028)

8.3 Asia Pacific Genitourinary Drugs Market Size by Region

8.3.1 Asia Pacific Genitourinary Drugs Sales by Region (2017-2028)

8.3.2 Asia Pacific Genitourinary Drugs Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Genitourinary Drugs Market Size by Type

9.1.1 Latin America Genitourinary Drugs Sales by Type (2017-2028)

9.1.2 Latin America Genitourinary Drugs Revenue by Type (2017-2028)

9.2 Latin America Genitourinary Drugs Market Size by Application

9.2.1 Latin America Genitourinary Drugs Sales by Application (2017-2028)

9.2.2 Latin America Genitourinary Drugs Revenue by Application (2017-2028)

9.3 Latin America Genitourinary Drugs Market Size by Country

9.3.1 Latin America Genitourinary Drugs Sales by Country (2017-2028)

9.3.2 Latin America Genitourinary Drugs Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Genitourinary Drugs Market Size by Type

10.1.1 Middle East and Africa Genitourinary Drugs Sales by Type (2017-2028)

10.1.2 Middle East and Africa Genitourinary Drugs Revenue by Type (2017-2028)

10.2 Middle East and Africa Genitourinary Drugs Market Size by Application

10.2.1 Middle East and Africa Genitourinary Drugs Sales by Application (2017-2028)

10.2.2 Middle East and Africa Genitourinary Drugs Revenue by Application (2017-2028)

10.3 Middle East and Africa Genitourinary Drugs Market Size by Country

10.3.1 Middle East and Africa Genitourinary Drugs Sales by Country (2017-2028)

10.3.2 Middle East and Africa Genitourinary Drugs Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 Novartis AG

11.1.1 Novartis AG Corporation Information

11.1.2 Novartis AG Overview

11.1.3 Novartis AG Genitourinary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 Novartis AG Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Novartis AG Recent Developments

11.2 Genentech

11.2.1 Genentech Corporation Information

11.2.2 Genentech Overview

11.2.3 Genentech Genitourinary Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Genentech Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Genentech Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Genitourinary Drugs Industry Chain Analysis

12.2 Genitourinary Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Genitourinary Drugs Production Mode & Process

12.4 Genitourinary Drugs Sales and Marketing

12.4.1 Genitourinary Drugs Sales Channels

12.4.2 Genitourinary Drugs Distributors

12.5 Genitourinary Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Genitourinary Drugs Industry Trends

13.2 Genitourinary Drugs Market Drivers

13.3 Genitourinary Drugs Market Challenges

13.4 Genitourinary Drugs Market Restraints

14 Key Findings in The Global Genitourinary Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Novartis

Genentech Inc

China

India

List of Tables

Table 1. Global Genitourinary Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Urologicals

Table 3. Major Manufacturers of Hormonal Therapy

Table 4. Major Manufacturers of Gynecological

Table 5. Major Manufacturers of Anti-infectives

Table 6. Global Genitourinary Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Genitourinary Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 8. Global Genitourinary Drugs Sales by Region (2017-2022) & (K Units)

Table 9. Global Genitourinary Drugs Sales Market Share by Region (2017-2022)

Table 10. Global Genitourinary Drugs Sales by Region (2023-2028) & (K Units)

Table 11. Global Genitourinary Drugs Sales Market Share by Region (2023-2028)

Table 12. Global Genitourinary Drugs Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Genitourinary Drugs Revenue Market Share by Region (2017-2022)

Table 14. Global Genitourinary Drugs Revenue by Region (2023-2028) & (US$ Million)

Table 15. Global Genitourinary Drugs Revenue Market Share by Region (2023-2028)

Table 16. Global Genitourinary Drugs Sales by Manufacturers (2017-2022) & (K Units)

Table 17. Global Genitourinary Drugs Sales Share by Manufacturers (2017-2022)

Table 18. Global Genitourinary Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 19. Global Genitourinary Drugs Revenue Share by Manufacturers (2017-2022)

Table 20. Genitourinary Drugs Price by Manufacturers (2017-2022) &(US$/Unit)

Table 21. Global Genitourinary Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Genitourinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genitourinary Drugs as of 2021)

Table 23. Genitourinary Drugs Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Genitourinary Drugs Product Offered

Table 25. Date of Manufacturers Enter into Genitourinary Drugs Market

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 28. Global Genitourinary Drugs Sales by Type (2023-2028) & (K Units)

Table 29. Global Genitourinary Drugs Sales Share by Type (2017-2022)

Table 30. Global Genitourinary Drugs Sales Share by Type (2023-2028)

Table 31. Global Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 32. Global Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 33. Global Genitourinary Drugs Revenue Share by Type (2017-2022)

Table 34. Global Genitourinary Drugs Revenue Share by Type (2023-2028)

Table 35. Genitourinary Drugs Price by Type (2017-2022) & (US$/Unit)

Table 36. Global Genitourinary Drugs Price Forecast by Type (2023-2028) & (US$/Unit)

Table 37. Global Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 38. Global Genitourinary Drugs Sales by Application (2023-2028) & (K Units)

Table 39. Global Genitourinary Drugs Sales Share by Application (2017-2022)

Table 40. Global Genitourinary Drugs Sales Share by Application (2023-2028)

Table 41. Global Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 42. Global Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 43. Global Genitourinary Drugs Revenue Share by Application (2017-2022)

Table 44. Global Genitourinary Drugs Revenue Share by Application (2023-2028)

Table 45. Genitourinary Drugs Price by Application (2017-2022) & (US$/Unit)

Table 46. Global Genitourinary Drugs Price Forecast by Application (2023-2028) & (US$/Unit)

Table 47. North America Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 48. North America Genitourinary Drugs Sales by Type (2023-2028) & (K Units)

Table 49. North America Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 50. North America Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 51. North America Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 52. North America Genitourinary Drugs Sales by Application (2023-2028) & (K Units)

Table 53. North America Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 54. North America Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 55. North America Genitourinary Drugs Sales by Country (2017-2022) & (K Units)

Table 56. North America Genitourinary Drugs Sales by Country (2023-2028) & (K Units)

Table 57. North America Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 58. North America Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 59. Europe Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 60. Europe Genitourinary Drugs Sales by Type (2023-2028) & (K Units)

Table 61. Europe Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 62. Europe Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 63. Europe Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 64. Europe Genitourinary Drugs Sales by Application (2023-2028) & (K Units)

Table 65. Europe Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 66. Europe Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 67. Europe Genitourinary Drugs Sales by Country (2017-2022) & (K Units)

Table 68. Europe Genitourinary Drugs Sales by Country (2023-2028) & (K Units)

Table 69. Europe Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 70. Europe Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 71. Asia Pacific Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 72. Asia Pacific Genitourinary Drugs Sales by Type (2023-2028) & (K Units)

Table 73. Asia Pacific Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 74. Asia Pacific Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 75. Asia Pacific Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 76. Asia Pacific Genitourinary Drugs Sales by Application (2023-2028) & (K Units)

Table 77. Asia Pacific Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 78. Asia Pacific Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 79. Asia Pacific Genitourinary Drugs Sales by Region (2017-2022) & (K Units)

Table 80. Asia Pacific Genitourinary Drugs Sales by Region (2023-2028) & (K Units)

Table 81. Asia Pacific Genitourinary Drugs Revenue by Region (2017-2022) & (US$ Million)

Table 82. Asia Pacific Genitourinary Drugs Revenue by Region (2023-2028) & (US$ Million)

Table 83. Latin America Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 84. Latin America Genitourinary Drugs Sales by Type (2023-2028) & (K Units)

Table 85. Latin America Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 86. Latin America Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 87. Latin America Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 88. Latin America Genitourinary Drugs Sales by Application (2023-2028) & (K Units)

Table 89. Latin America Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 90. Latin America Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 91. Latin America Genitourinary Drugs Sales by Country (2017-2022) & (K Units)

Table 92. Latin America Genitourinary Drugs Sales by Country (2023-2028) & (K Units)

Table 93. Latin America Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 94. Latin America Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 95. Middle East and Africa Genitourinary Drugs Sales by Type (2017-2022) & (K Units)

Table 96. Middle East and Africa Genitourinary Drugs Sales by Type (2023-2028) & (K Units)

Table 97. Middle East and Africa Genitourinary Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 98. Middle East and Africa Genitourinary Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 99. Middle East and Africa Genitourinary Drugs Sales by Application (2017-2022) & (K Units)

Table 100. Middle East and Africa Genitourinary Drugs Sales by Application (2023-2028) & (K Units)

Table 101. Middle East and Africa Genitourinary Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 102. Middle East and Africa Genitourinary Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 103. Middle East and Africa Genitourinary Drugs Sales by Country (2017-2022) & (K Units)

Table 104. Middle East and Africa Genitourinary Drugs Sales by Country (2023-2028) & (K Units)

Table 105. Middle East and Africa Genitourinary Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 106. Middle East and Africa Genitourinary Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 107. Novartis AG Corporation Information

Table 108. Novartis AG Description and Major Businesses

Table 109. Novartis AG Genitourinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 110. Novartis AG Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Novartis AG Recent Developments

Table 112. Genentech Corporation Information

Table 113. Genentech Description and Major Businesses

Table 114. Genentech Genitourinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)

Table 115. Genentech Genitourinary Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Genentech Recent Developments

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Genitourinary Drugs Distributors List

Table 120. Genitourinary Drugs Customers List

Table 121. Genitourinary Drugs Market Trends

Table 122. Genitourinary Drugs Market Drivers

Table 123. Genitourinary Drugs Market Challenges

Table 124. Genitourinary Drugs Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Genitourinary Drugs Product Picture

Figure 3. Global Genitourinary Drugs Market Share by Type in 2021 & 2028

Figure 3. Urologicals Product Picture

Figure 4. Hormonal Therapy Product Picture

Figure 5. Gynecological Product Picture

Figure 6. Anti-infectives Product Picture

Figure 7. Global Genitourinary Drugs Market Share by Application in 2021 & 2028

Figure 8. Prostate Cancer

Figure 9. Ovarian Cancer

Figure 10. Bladder Cancer

Figure 11. Cervical Cancer

Figure 12. Renal Cancer

Figure 13. Erectile Dysfunction

Figure 14. Urinary Tract Infections

Figure 15. Urinary Incontinence & Overactive Bladder

Figure 16. Sexually Transmitted Diseases

Figure 17. Genitourinary Drugs Report Years Considered

Figure 18. Global Genitourinary Drugs Sales 2017-2028 (K Units)

Figure 19. Global Genitourinary Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 20. Global Genitourinary Drugs Revenue 2017-2028 (US$ Million)

Figure 21. Global Genitourinary Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 22. Global Genitourinary Drugs Sales Market Share by Region (2017-2022)

Figure 23. Global Genitourinary Drugs Sales Market Share by Region (2023-2028)

Figure 24. North America Genitourinary Drugs Sales YoY (2017-2028) & (K Units)

Figure 25. North America Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 26. Europe Genitourinary Drugs Sales YoY (2017-2028) & (K Units)

Figure 27. Europe Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 28. Asia-Pacific Genitourinary Drugs Sales YoY (2017-2028) & (K Units)

Figure 29. Asia-Pacific Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 30. Latin America Genitourinary Drugs Sales YoY (2017-2028) & (K Units)

Figure 31. Latin America Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 32. Middle East & Africa Genitourinary Drugs Sales YoY (2017-2028) & (K Units)

Figure 33. Middle East & Africa Genitourinary Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 34. The Genitourinary Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 35. The Top 5 and 10 Largest Manufacturers of Genitourinary Drugs in the World: Market Share by Genitourinary Drugs Revenue in 2021

Figure 36. Global Genitourinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 37. Global Genitourinary Drugs Sales Market Share by Type (2017-2028)

Figure 38. Global Genitourinary Drugs Revenue Market Share by Type (2017-2028)

Figure 39. Global Genitourinary Drugs Sales Market Share by Application (2017-2028)

Figure 40. Global Genitourinary Drugs Revenue Market Share by Application (2017-2028)

Figure 41. North America Genitourinary Drugs Sales Market Share by Type (2017-2028)

Figure 42. North America Genitourinary Drugs Revenue Market Share by Type (2017-2028)

Figure 43. North America Genitourinary Drugs Sales Market Share by Application (2017-2028)

Figure 44. North America Genitourinary Drugs Revenue Market Share by Application (2017-2028)

Figure 45. North America Genitourinary Drugs Sales Share by Country (2017-2028)

Figure 46. North America Genitourinary Drugs Revenue Share by Country (2017-2028)

Figure 47. U.S. Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 48. Canada Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 49. Europe Genitourinary Drugs Sales Market Share by Type (2017-2028)

Figure 50. Europe Genitourinary Drugs Revenue Market Share by Type (2017-2028)

Figure 51. Europe Genitourinary Drugs Sales Market Share by Application (2017-2028)

Figure 52. Europe Genitourinary Drugs Revenue Market Share by Application (2017-2028)

Figure 53. Europe Genitourinary Drugs Sales Share by Country (2017-2028)

Figure 54. Europe Genitourinary Drugs Revenue Share by Country (2017-2028)

Figure 55. Germany Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 56. France Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 57. U.K. Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 58. Italy Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 59. Russia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 60. Asia Pacific Genitourinary Drugs Sales Market Share by Type (2017-2028)

Figure 61. Asia Pacific Genitourinary Drugs Revenue Market Share by Type (2017-2028)

Figure 62. Asia Pacific Genitourinary Drugs Sales Market Share by Application (2017-2028)

Figure 63. Asia Pacific Genitourinary Drugs Revenue Market Share by Application (2017-2028)

Figure 64. Asia Pacific Genitourinary Drugs Sales Share by Region (2017-2028)

Figure 65. Asia Pacific Genitourinary Drugs Revenue Share by Region (2017-2028)

Figure 66. China Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 67. Japan Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 68. South Korea Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 69. India Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 70. Australia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 71. Taiwan Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 72. Indonesia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 73. Thailand Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 74. Malaysia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 75. Philippines Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 76. Latin America Genitourinary Drugs Sales Market Share by Type (2017-2028)

Figure 77. Latin America Genitourinary Drugs Revenue Market Share by Type (2017-2028)

Figure 78. Latin America Genitourinary Drugs Sales Market Share by Application (2017-2028)

Figure 79. Latin America Genitourinary Drugs Revenue Market Share by Application (2017-2028)

Figure 80. Latin America Genitourinary Drugs Sales Share by Country (2017-2028)

Figure 81. Latin America Genitourinary Drugs Revenue Share by Country (2017-2028)

Figure 82. Mexico Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 83. Brazil Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 84. Argentina Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 85. Middle East and Africa Genitourinary Drugs Sales Market Share by Type (2017-2028)

Figure 86. Middle East and Africa Genitourinary Drugs Revenue Market Share by Type (2017-2028)

Figure 87. Middle East and Africa Genitourinary Drugs Sales Market Share by Application (2017-2028)

Figure 88. Middle East and Africa Genitourinary Drugs Revenue Market Share by Application (2017-2028)

Figure 89. Middle East and Africa Genitourinary Drugs Sales Share by Country (2017-2028)

Figure 90. Middle East and Africa Genitourinary Drugs Revenue Share by Country (2017-2028)

Figure 91. Turkey Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 92. Saudi Arabia Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 93. UAE Genitourinary Drugs Revenue (2017-2028) & (US$ Million)

Figure 94. Genitourinary Drugs Value Chain

Figure 95. Genitourinary Drugs Production Process

Figure 96. Channels of Distribution

Figure 97. Distributors Profiles

Figure 98. Bottom-up and Top-down Approaches for This Report

Figure 99. Data Triangulation

Figure 100. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Genitourinary Drugs Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-38T2103

Genitourinary Drugs Market Insights, Forecast to 2028

FEATURED COMPANIES

Genitourinary Drugs Market Outlook - 2028

Genitourinary Drugs Market Insights

Genitourinary Drugs Market Scope and Segment

Segment by Type

Segment by Application

By Company

By Region

FEATURED COMPANIES

Global Oleochemicals Market Research Report 2022

Single User, Electronic (PDF)